Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

I. Male or female subjects who are â?¥18 years of age, on the day of signing informed consent. <br/ >II. Patient or Legally Acceptable Representative (LAR) willing to give informed Consent before study procedure. <br/ >III. Hospitalized with COVID-19 infection confirmed per WHO criteria (including a positive PCR of any specimen, e.g., respiratory, blood, urine, stool, other bodily fluid). <br/ >IV. Moderate to severe COVID 19 infection (moderate disease â?? increased respiratory rate 15 to 30/minute and SpO2 90%-94%, and severe disease - respiratory rate â?¥ 30/minute and/or SpO2 < 90% on room air, or ARDS or Septic shock <br/ >

I. Male or female subjects who are â?¥18 years of age, on the day of signing informed consent. <br/ >II. Patient or Legally Acceptable Representative (LAR) willing to give informed Consent before study procedure. <br/ >III. Hospitalized with COVID-19 infection confirmed per WHO criteria (including a positive PCR of any specimen, e.g., respiratory, blood, urine, stool, other bodily fluid). <br/ >IV. Moderate to severe COVID 19 infection (moderate disease â?? increased respiratory rate 15 to 30/minute and SpO2 90%-94%, and severe disease - respiratory rate â?¥ 30/minute and/or SpO2 < 90% on room air, or ARDS or Septic shock <br/ >

Nov. 13, 2021, 5:33 p.m. oms

Oct. 26, 2020, 8:29 a.m. oms

I. Male or female subjects who are â?¥18 years of age, on the day of signing informed consent. <br/ >II. Patient or Legally Acceptable Representative (LAR) willing to give informed Consent before study procedure. <br/ >III. Hospitalized with COVID-19 infection confirmed per WHO criteria (including a positive PCR of any specimen, e.g., respiratory, blood, urine, stool, other bodily fluid). <br/ >IV. Moderate to severe COVID 19 infection (moderate disease â?? increased respiratory rate 15 to 30/minute and SpO2 90%-94%, and severe disease - respiratory rate â?¥ 30/minute and/or SpO2 < 90% on room air, or ARDS or Septic shock <br/ >

I. Male or female subjects who are â?¥18 years of age, on the day of signing informed consent. <br/ >II. Patient or Legally Acceptable Representative (LAR) willing to give informed Consent before study procedure. <br/ >III. Hospitalized with COVID-19 infection confirmed per WHO criteria (including a positive PCR of any specimen, e.g., respiratory, blood, urine, stool, other bodily fluid). <br/ >IV. Moderate to severe COVID 19 infection (moderate disease â?? increased respiratory rate 15 to 30/minute and SpO2 90%-94%, and severe disease - respiratory rate â?¥ 30/minute and/or SpO2 < 90% on room air, or ARDS or Septic shock <br/ >